The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies

被引：11
作者：
Norman, Jane E. [1 ]
Schouten, Harry C. [2 ]
Dreger, Peter [3 ]
Robinson, Stephen P. [4 ]
机构：
[1] Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England
[2] Univ Hosp Maastricht, Dept Internal Med Hematol, Maastricht, Netherlands
[3] Heidelberg Univ, Dept Haematol & Oncol, Heidelberg, Germany
[4] Bristol Oncol & Haematol Ctr, Dept Haematol, Bristol, Avon, England
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷 / 06期
关键词：
NON-HODGKIN-LYMPHOMA; TERM-FOLLOW-UP; BONE-MARROW-TRANSPLANTATION; PROGRESSION-FREE SURVIVAL; HIGH-DOSE THERAPY; CHRONIC LYMPHOCYTIC-LEUKEMIA; CHIMERIC-ANTIGEN-RECEPTOR; LOW-GRADE; OPEN-LABEL; PHASE-II;
D O I：
10.1038/s41409-018-0372-5
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Patients with relapsed follicular lymphoma (FL) following first-line therapy have an increasing number of management strategies ranging from observation through to stem cell transplantation. There has been an exciting expansion in novel agents to treat FL, but at present there is not a universally accepted standard of care in the relapse setting. Decision-making can be difficult for the clinician as there is a paucity of data to compare the various relapse therapies available. This review will discuss conventional therapy for relapsed FL, consider the use of novel agents and explore the role and timing of autologous and allogeneic stem cell transplantation.
引用
收藏
页码：787 / 797
页数：11
相关论文
共 50 条
  • [41] Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure
    Jimenez-Ubieto, Ana
    Grande, Carlos
    Caballero, Dolores
    Yanez, Lucrecia
    Novelli, Silvana
    Teodoro Hernandez-Garcia, Miguel
    Manzanares, Maria
    Arranz, Reyes
    Javier Ferreiro, Jose
    Bobillo, Sabella
    Mercadal, Santiago
    Galeo, Andrea
    Lopez Jimenez, Javier
    Maria Moraleda, Jose
    Vallejo, Carlos
    Albo, Carmen
    Perez, Elena
    Marrero, Carmen
    Magnano, Laura
    Palomera, Luis
    Jarque, Isidro
    Martinez-Sanchez, Pilar
    Martin, Alejandro
    Coria, Erika
    Lopez-Guillermo, Armando
    Salar, Antonio
    Jose Lahuerta, Juan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (10) : 1631 - 1640
  • [42] Current Status of Targeted Therapies for Mantle Cell Lymphoma
    Chang, Julie E.
    Kahl, Brad S.
    DRUGS, 2011, 71 (17) : 2307 - 2326
  • [43] Autoimmune Cytopenia in CLL Prognosis and Management in the Era of Targeted Therapies
    Albiol, Nil
    Moreno, Carol
    CANCER JOURNAL, 2021, 27 (04) : 286 - 296
  • [44] Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review
    Fowler, Nathan Hale
    Chavez, Julio C.
    Riedell, Peter A.
    TARGETED ONCOLOGY, 2024, 19 (04) : 495 - 510
  • [45] Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party
    Montoto, Silvia
    Corradini, Paolo
    Dreyling, Martin
    Ghielmini, Michele
    Kimby, Eva
    Lopez-Guillermo, Armando
    Mackinnon, Stephen
    Marcus, Robert E.
    Salles, Gilles
    Schouten, Harry C.
    Sureda, Anna
    Dreger, Peter
    HAEMATOLOGICA, 2013, 98 (07) : 1014 - 1021
  • [46] Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective
    Veilleux, Olivier
    Claveau, Jean-Sebastien
    Alaoui, Habiba
    Roy, Jean
    Ahmad, Imran
    Delisle, Jean-Sebastien
    Kiss, Thomas
    Bambace, Nadia M.
    Bernard, Lea
    Cohen, Sandra
    Sauvageau, Guy
    Fleury, Isabelle
    Mollica, Luigina
    Roy, Denis-Claude
    Serroukh, Yasmina
    Lachance, Sylvie
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (03): : 145 - 151
  • [47] Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade
    Apostolidis, John
    Mokhtar, Nihad
    Al Omari, Rawan
    Darweesh, Mohammed
    Al Hashmi, Hani
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (03) : 213 - 221
  • [48] Role of stem cell transplant in lymphoma in the era of new drugs
    Benekou, Katerina
    Montoto, Silvia
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (06) : 455 - 459
  • [49] The Persistent Uncertainty of When to Recommend Allogeneic Stem Cell Transplantation in Follicular Lymphoma
    Sorigue, Marc
    Sancho, Juan-Manuel
    CANCER, 2018, 124 (16) : 3454 - 3455
  • [50] Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma
    Tam C.S.
    Khouri I.
    Current Hematologic Malignancy Reports, 2007, 2 (4) : 225 - 231
12345